Markets & Infrastructure

    Structural Regulation

    Philippines Eases Bank Branch Opening Rules

    By Samuel Riding | 12/12/2016

    Lenders will now be able to set up branches in previously restricted areas.

    Market Abuse

    Indian Gov’t Says NSE Gave Preferential Access

    By Samuel Riding | 12/12/2016

    Finance minister Arjun Meghwal says loophole making system prone to manipulation closed on 3 December.

    Fraud, Scams & Cybercrime

    China Launches Acceptance Bills Exchange

    By Samuel Riding | 09/12/2016

    New exchange aims to prevent fraud amidst PBOC concerns about ‘opaque information trading’.

    Payments & Settlements

    SGX Glitch Halts Derivatives Trading

    By Samuel Riding | 09/12/2016

    December Nikkei 225 Futures the largest contract hit by delay 5 months after main board malfunction.

    Conduct, Culture & Accountability

    Taiwan FSC Fines ANZ for TRF Mis-selling

    By Samuel Riding | 09/12/2016

    Investigation finds ANZ helped customers buy RMB-linked forwards for which they were unfit.

    Trading & Investment

    Tax Reform a Boon for Overseas Investors

    By Samuel Riding | 09/12/2016

    Simpler, more rational regime is increasingly conducive, EY partner Tejas Desai suggests.

    Structural Regulation

    The Big Picture – Indian Regulatory Outlook

    By Samuel Riding | 08/12/2016

    Highlights from Regulation Asia’s 2016 India Roundtable with ICCL, Stockholding, EY and PIVOT.

    Structural Regulation

    Thailand ‘Sandbox’ to Allow 3 Fintech Services

    By Samuel Riding | 08/12/2016

    Regulator to allow work on private funds, investment advice, clearing and settlement.

    Trading & Investment

    PSE Kicks off USD Securities Regime

    By Samuel Riding | 08/12/2016

    Exchange to hold training sessions for traders and back office staff; expects REIT regulation soon.

    Structural Regulation

    ASIC Issues Licensing Report

    By Samuel Riding | 07/12/2016

    Regulator concerned by misleading applications, overseas misrepresentation by OTC derivative licensees.

    JOIN OUR NEWSLETTER

    An exclusive weekly selection of top stories from the Regulation Asia editorial team.